Оваген
Ovagen bioregulator peptide (Khavinson school). Limited primary literature; full source PDFs preserved in the dossier.
1 · Identity
- Identity
- sequence-only / literature
2 · Mechanism — what the primary literature actually shows
Polypeptide fraction from bovine ovaries — tissue-specific reproductive bioregulator. Direct primary literature on Ovagen® product is sparse. Most adjacent literature covers: (1) constant light exposure → anovulation + female reproductive cancer (Anisimov 2003); (2) melatonin in obstetrics/gynaecology (Gafarova-Maltseva 2014); (3) goat embryo cryopreservation quality (Aksenova-Aibazov-Seitov 2013); (4) thymosin-α1 effects on B-cells in pigs (Molyanova 2013); (5) goat polyovulation induction for embryo transplantation — uses peptide combinations (Aksenova 2013). The Khavinson-school ovarian peptide concept is established but under-published on dedicated Ovagen® product studies.
How it works
Key findings (4)
- Adjacent: goat polyovulation induction — peptide combinations used to overcome donor variability (Aksenova 2013)
- Adjacent: constant light exposure effects on anovulation and cancer risk (Anisimov 2003)
- Adjacent: embryo cryopreservation quality (Aksenova 2013)
- No DIRECT Ovagen® product studies identified in CyberLeninka audit
Evidence quality
Very low. No direct Ovagen® studies. Adjacent reproductive biology literature is strong but not directly about this compound.
Open questions (3)
- Dedicated Ovagen® pharmacology
- Clinical use in human reproductive medicine (anovulation, IVF adjunct)
- Comparison with gonadotropins
3 · Summary
Design distribution
| Design | Count | Distribution |
|---|
4 · Possible mechanisms — candidate list
5 · Pathways — questions the corpus does not yet answer
- Pathway
- Falsification experiment for open question 1. Dedicated Ovagen® pharmacology
- Blocked by
- See synthesis evidence quality section for barriers.
- Pathway
- Falsification experiment for open question 2. Clinical use in human reproductive medicine (anovulation, IVF adjunct)
- Blocked by
- See synthesis evidence quality section for barriers.
- Pathway
- Falsification experiment for open question 3. Comparison with gonadotropins
- Blocked by
- See synthesis evidence quality section for barriers.
6 · Bibliography — Russian primary sources
- svetovoy-rezhim-anovulyatsiya-i-risk-zlokachestvennyh-novoobrazovaniy-zhenskoy-reproduktivnoy-sistemy-mehanizmy-svyazi-i-profilaktika
- primenenie-melatonina-v-akushersko-ginekologicheskoy-praktike
- otsenka-kachestva-i-ustoychivosti-k-kriokonservatsii-embrionov-koz-v-zavisimosti-ot-stadii-razvitiya
- vliyanie-timozina-1-na-dinamiku-v-kletok-v-krovi-chistoporodnyh-sviney-v-rannem-postnatalnom-ontogeneze
- effektivnaya-shema-induktsii-poliovulyatsii-dlya-transplantatsii-embrionov-u-koz
- kriorezistentnost-embrionov-koz-v-zavisimosti-ot-stadii-razvitiya
- ekonomicheskaya-bezopasnost-kak-osnovnoy-element-antikrizisnogo-upravleniya-ekonomicheskim-subektom
- starenie-fiziologicheskoe-i-prezhdevremennoe-sovremennyy-vzglyad-na-problemu
- problema-diagnostiki-i-korrektsii-donozologicheskogo-statusa-cheloveka
- razrabotka-effektivnyh-shem-induktsii-poliovulyatsii-u-molochnyh-koz-s-primeneniem-razlichnyh-preparatov
- ctan-i-perspektivi-zastosuvannya-biotehnologichnih-metodiv-vidtvorennya-u-pleminnomu-vivcharstvi
- variabelnost-otveta-yaichnikov-pri-induktsii-poliovulyatsii-u-koz
- vliyanie-polipeptidnyh-kompleksov-na-razvitie-organotipicheskoy-kultury-tkani-kozhi-krys-raznogo-vozrasta
- rezultaty-aprobatsii-usovershenstvovannogo-metoda-transplantatsii-embrionov-u-ovets-analiz-prizhivlyaemosti-zigot-effektivnosti
- vliyanie-peptidnyh-bioregulyatorov-na-strukturno-funktsionalnye-osobennosti-kozhi-litsa-zhenschin-pozhilogo-vozrasta
- sochetannoe-vliyanie-polipeptidnyh-kompleksov-na-razvitie-organotipicheskoy-kultury-tkaney-krys
- sovremennaya-pischevaya-biotehnologiya-osnovnye-problemy-i-vyzovy
- rezultaty-stimulyatsii-follikulogeneza-u-zaanenskih-koz
- issledovanie-biologicheskoy-aktivnosti-peptidov-poluchennyh-izvnutrennih-organov-zhivotnyh-perenesshih-ostruyu-krovopoteryu
- lekarstvennye-peptidnye-preparaty-proshloe-nastoyaschee-buduschee
- bioantioksidanty-chast-2
Inventor (detail): V.Kh. Khavinson + N.S. Linkova lab
First publication: 2010s
Peptide kind: Synthetic short peptide (Cytomed R&D)
Below: substantive excerpts from 6 Russian primary papers. Click each title to expand the Russian/English abstract.
6/6 papers with substantive abstracts · 5,186 characters of Russian/English pharmacological text extracted · 6 Russian abstracts · 5 English abstracts · 1/6 relevance-classified.
Extracted findings (0 models · 1 mechanism terms · direction: ↑2 ↓1 ↺0 across 6 papers)
- Model organisms
- —
- Doses / concentrations
- 1 мл, 7 мл
- Mechanism terms
- тимуса
- Effect direction
- 2× increase · 1× decrease · 0× restoration/normalisation
[2003] Световой режим, ановуляция и риск злокачественных новообразований женской репродуктивной системы: механизмы связи и проф
[2014] Применение мелатонина в акушерско-гинекологической практике
[2013] Оценка качества и устойчивости к криоконсервации эмбрионов коз в зависимости от стадии развития
[2011] ВЛИЯНИЕ ТИМОЗИНА-α1 НА ДИНАМИКУ В-КЛЕТОК В КРОВИ ЧИСТОПОРОДНЫХ СВИНЕЙ В РАННЕМ ПОСТНАТАЛЬНОМ ОНТОГЕНЕЗЕ
[2013] Эффективная схема индукции полиовуляции для трансплантации эмбрионов у коз
[2013] Криорезистентность эмбрионов коз в зависимости от стадии развития
7 · Bibliography — PubMed corpus
| PMID | Year | Design | n | Grade | COI | Title |
|---|
8 · Corroboration
- Corpus source
- PubMed (eutils) and OpenAlex, swept against this compound by PMID. Last verified 26.08.2026.
- Identity source
- PubChem CID — verified live. InChIKey —. Live fetch on 26.08.2026.
- Provenance
- Saint Petersburg Institute of Bioregulation and Gerontology (2010) V.Kh. Khavinson — Cytomed peptide bioregulator
9 · Open questions
- Zero A- or B-grade evidence in the corpus. No registered RCT with disclosed n.